Forced sterilization a symptom of ‘colonial hangover’ says lawyer
By Dennis Ward,
Face to Face
| 04. 07. 2020
More than 100 Indigenous women in Canada have come forward with stories of forced or coerced sterilization and lawyer Alisa Lombard says it’s nothing new in Canada, nor is it illegal.
More than 100 Indigenous women in Canada have come forward with stories of forced or coerced sterilization and lawyer Alisa Lombard says it’s nothing new in Canada, nor is it illegal.
“I think that the practice of forced sterilization is symptomatic of a colonial hangover. And I think it has a lot to do with eugenics of course, these old ideas that some people should have children and others are not fit to,” Lombard told Face to Face. “Eugenics was a widely accepted theory not so long ago. It was a theory that was attempted to be brought into legislation in Saskatchewan and only failed by one vote.
“It was, in fact, brought into legislation in Alberta and British Columbia.”
Lombard is a partner with Saskatchewan based, Semanganis Worme Lombard and is heading up a proposed class action lawsuit representing Indigenous women who have been forced or coerced into sterilization.
Forced sterilization is a procedure more commonly known as getting your tubes tied, but without the proper and informed consent of the woman involved.
Those women, and potentially many more...
Related Articles
By Vittoria Vardanega, SWI swissinfo.ch | 02.13.2026
In recent years, sperm donation has produced family trees of unprecedented size, stretching across countries and, in some cases, continents. Stories of “mass donors” have captured public attention, most recently through the Netflix documentary series, The Man with 1,000 Kids...
By Jonathan D. Moreno, Hastings Center Bioethics Forum | 02.09.2026
When I began to write a book about bioethics and the rules-based international order, the idea that the world was facing the greatest geopolitical change since World War II was uncontroversial for those who were paying attention to such esoterica...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...